Anne Yeakey
Impact in
- Physiology top 10%
- Asthma and respiratory diseases
-
- Multiple Myeloma Research and Treatments
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
-
- Influenza Virus Research Studies 4
- Data-Driven Disease Surveillance 1
- Co-authors
- David A. Stempel (6 shared papers)Ibrahim Raphiou (6 shared papers)Steven Pascoe (3 shared papers)Kenneth M. Kral (4 shared papers)Charlene M. Prazma (2 shared papers)Amanda Emmett (2 shared papers)Andrew H. Liu (1 shared paper)Barbara A. Prillaman (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Blood (2 papers)New England Journal of Medicine (2 papers)The Lancet Infectious Diseases (2 papers)Therapeutic Innovation & Regulatory Science (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Anne Yeakey
19 papers receiving 312 citations
Peers
Comparison fields: 5 of 37
- Physiology 171
- Hematology 57
- Pulmonary and Respiratory Medicine 107
- Immunology and Allergy 13
- Oncology 47
Countries citing papers authored by Anne Yeakey
This map shows the geographic impact of Anne Yeakey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Yeakey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Yeakey more than expected).
Fields of papers citing papers by Anne Yeakey
This network shows the impact of papers produced by Anne Yeakey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Yeakey. The network helps show where Anne Yeakey may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Yeakey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 104 | |
| 2 | 2016 | 78 | |
| 3 | 2020 | 32 | |
| 4 | 2019 | 18 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 15 | |
| 7 | 2013 | 13 | |
| 8 | 2019 | 8 | |
| 9 | 2019 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2019 | 5 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 4 | |
| 15 | 2016 | 2 | |
| 16 | 2014 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2016 | 1 |
About Anne Yeakey
Anne Yeakey is a scholar working on Infectious Diseases, Epidemiology, Physiology, Hematology and Molecular Biology, having authored 19 papers that have together received 321 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), Multiple Myeloma Research and Treatments (4 papers), Influenza Virus Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Ubiquitin and proteasome pathways (1 paper), Data-Driven Disease Surveillance (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Physiology (171 citations), Hematology (57 citations), Pulmonary and Respiratory Medicine (107 citations), Immunology and Allergy (13 citations) and Oncology (47 citations). Anne Yeakey has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include David A. Stempel, Ibrahim Raphiou, Steven Pascoe, Kenneth M. Kral, Charlene M. Prazma, Amanda Emmett, Andrew H. Liu, Barbara A. Prillaman, Herman Mitchell and Søren Pedersen. Their work appears in journals such as Journal of Clinical Oncology, Blood, New England Journal of Medicine, The Lancet Infectious Diseases and Therapeutic Innovation & Regulatory Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.